Day-case holmium laser enucleation and mechanical morcellation of the prostate [Ambulante Holmiumlasere-nukleation und mechanische Morcellierung der Prostata]

被引：0
作者：
Abrolat R. [1 ]
Langer K. [1 ]
Roos N. [1 ]
机构：
[1] Urologisches Zentrum Neustadt, 67434 Neustadt/Weinstr
来源：
Der Urologe | 2009年 / 48卷 / 12期
关键词：
BPH; Day-case; HoLEP; Laser; Morcellation;
D O I：
10.1007/s00120-009-2099-9
中图分类号：
学科分类号：
摘要：
Background: Holmium laser enucleation of the prostate (HoLEP) is increasingly being used as an alternative to transurethral resection of the prostate (TURP) and transurethral electrovaporisation of the prostate (TVP), the"gold standard" procedures for treating symptomatic benign prostatic hyperplasia. Mechanical tissue morcellation was introduced in 1998, and its efficiency could be improved. We investigated the efficiency and complication rate of a morcellator in a day-case setting. Methods: From 2004 to 2008, 137 men were treated with an 80W holmium:YAG laser and subsequent tissue morcellation. Results: The average patient age was 68.0±7.1 (51-86) years. Morcellation time was 8.6±6.8 (1-35) min. The weight of the resected tissue was 36.6±30.0 (2-175) g. The total time for the procedure was 69.6±28.7 (29-150) min, and the efficiency of morcellation was 5.0±2.6 (0.2-11.5) g/min. The complication rate due to morcellation was 4.3%. Conclusion: HoLEP with mechanical morcellation is safe even in a day-case setting. The total procedure time approximates that for TURP, so a longer theatre time loses significance as an argument against the method. Complications are rare and not severe. Further technical improvement is desirable. © 2009 Springer Medizin Verlag.
引用
收藏
页码：1490 / 1494
页数：4
相关论文
共 30 条
  • [11] Kuntz R., Holmium-Laser-Enukleatiion neuer, Goldstandard". Uro-News, 5, (2006)
  • [12] Kuntz R.M., Lehrich K., Transurethral holmium laser enucleation versus transvesical open enucleation for prostate adenoma greater than 100 gm.: A randomized prospective trial of 120 patients, J Urol, 168, pp. 1465-1469, (2002)
  • [13] Kuntz R., Lehrich K., Ahyai S., Transurethrale holmium-laser-enukleation der prostata ( HoLEP): Eine sichere und effektive endourologische Alternative zur offenen Adenomenukleation, Akt Urol, 33, pp. 357-363, (2002)
  • [14] Kuo R.L., Kim S.C., Lingeman J.E., Et al., Holmium laser enucleation of prostate (HoLEP): The Methodist Hospital experience with greater than 75 gram enucleations, J Urol, 170, pp. 149-152, (2003)
  • [15] Kuo R.L., Ryan F.P., Samuel C.K., Et al., Lingeman holmium laser enucleation of the prostate (HoLEP):A Technical Update, World J Surg Oncol i, 6, pp. 1-9, (2003)
  • [16] Larner T.R.G., Agarwal D., Costello A.J., Day-case holmium laser enucleation of the prostate for gland volumes of 60 mL: Early experience, BJU Int, 91, pp. 61-64, (2003)
  • [17] Matlaga B.R., Kim S.C., Kuo R.L., Et al., Holmium laser enucleation of the prostate for prostates of >125 mL, BJU, 97, pp. 81-84, (2006)
  • [18] Matlaga B.R., Miller N.L., Lingeman J.E., Holmium laser treatment of benign prostatic hyperplasia: An update, Curr Opin Urol, 17, pp. 27-31, (2007)
  • [19] Millin T.J., Retropubic prostatectomy, Lancet, 2, pp. 693-696, (1945)
  • [20] Montorsi F., Naspro R., Salonia A., Et al., Holmium laser enucleation versus transurethral resection of the prostate: Results from a 2-center, prospective, randomized trial in patients with obstructive benign prostatic hyperplasia, J Urol, 179, pp. 87-90, (2008)
123